Zaid Al‐Kadhimi

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)

Javier Bolaños‐Meade, Ran Reshef, Raphael Fraser et al. · The Lancet Haematology · 2019 · 274 citations

Versus Tacrolimus, Transplantation, Immunosuppressive Therapy +9

Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy

Mohamed A. Kharfan‐Dabaja, Ambuj Kumar, Ernesto Ayala et al. · Transplantation and Cellular Therapy · 2021 · 165 citations · Full text

Enhanced antilymphoma efficacy of CD19-redirected influenza MP1–specific CTLs by cotransfer of T cells modified to present influenza MP1

Laurence J.N. Cooper, Zaid Al‐Kadhimi, Lisa Marie Serrano et al. · Blood · 2004 · 109 citations · Full text

Targeted T-cell Therapy in Stage IV Breast Cancer: A Phase I Clinical Trial

Lawrence G. Lum, Archana Thakur, Zaid Al‐Kadhimi et al. · Clinical Cancer Research · 2015 · 105 citations · Full text

Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy

Lisa Marie Serrano, Timothy Pfeiffer, Simon Olivares et al. · Blood · 2005 · 93 citations · Full text